Concordance of clinical and environmental isolates of Cryptococcus neoformans var gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting

被引:105
|
作者
Sorrell, TC
Chen, SCA
Ruma, P
Meyer, W
Pfeiffer, TJ
Ellis, DH
Brownlee, AG
机构
[1] WESTMEAD HOSP,CTR INFECT DIS & MICROBIOL,WESTMEAD,NSW 2145,AUSTRALIA
[2] UNIV SYDNEY,CTR INFECT DIS & MICROBIOL,WESTMEAD,NSW 2145,AUSTRALIA
[3] CSIRO,DIV ANIM PROD,BLACKTOWN,NSW 2148,AUSTRALIA
[4] WOMENS & CHILDRENS HOSP,ADELAIDE,SA,AUSTRALIA
关键词
D O I
10.1128/JCM.34.5.1253-1260.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Sixty one clinical and forty-nine environmental isolates of Cryptococcus neoformans var. gattii from Australia and the United States were analyzed by random amplification of polymorphic DNA (RAPD), using 12- to 22-mer primers in pairs, and/or PCR fingerprinting with a single primer derived from the microsatellite core sequence of the wild-type phage M13 (5' GAGGGTGGCGGTTCT 3'), Three major genetic profiles were identified by both typing techniques, A single RAPD profile (VGI) predominated among clinical isolates (44 of 48, 92%) and isolates from host eucalypts (45 of 45, 100%) from Australia, Of the 94 Australian isolates, 4 (3 clinical and 1 environmental) were assigned to profile VGII; 2 of these were recovered from patients and one was recovered from plant debris from Western Australia, Only one Australian clinical isolate was assigned to profile VGIII, A different distribution of RAPD profiles (four VGIII, two VGII, and one VGI) was found among four clinical and three environmental isolates from the United States, RAPD profiles of 8 of the 101 isolates studied revealed minor genetic variants, 4 of profile VGI and 4 of profile VGII, Genetic concordance between the majority of clinical and environmental isolates in Australia is consistent with the hypothesis that human disease is acquired from exposure to host eucalypts, Profiles of clinical isolates were independent of body site of infection, and profiles of all isolates were stable over time. Analysis by PCR fingerprinting confirmed the RAPD results, A second RAPD profile (VGII) was associated with infection in southwest Western Australia, where the two host eucalypts do not occur naturally, This raises the possibility of an alternative and as yet unidentified natural habitat of C. neoformans var. gattii. Our results indicate that RAPD analysis is a sensitive and useful method for investigating environmental sources of human infection with this biotype.
引用
收藏
页码:1253 / 1260
页数:8
相关论文
共 50 条
  • [1] PCR FINGERPRINTING CRYPTOCOCCUS-NEOFORMANS BY RANDOM AMPLIFICATION OF POLYMORPHIC DNA
    CRAMPIN, AC
    MATTHEWS, RC
    HALL, D
    EVANS, EGV
    JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1993, 31 (06): : 463 - 465
  • [2] Genotypes of Clinical and Environmental Isolates of Cryptococcus neoformans and Cryptococcus gattii in Korea
    Park, So Hae
    Choi, Seok Cheol
    Lee, Kyung Won
    Kim, Mi-Na
    Hwang, Soo Myung
    MYCOBIOLOGY, 2015, 43 (03) : 360 - 365
  • [3] Identification of clinical and environmental isolates of Cryptococcus neoformans by AP-PCR fingerprinting
    温海
    吴建华
    廖万清
    陈江汉
    中华医学杂志(英文版), 1998, (04)
  • [4] Identification of clinical and environmental isolates of Cryptococcus neoformans by AP-PCR fingerprinting
    温海
    吴建华
    廖万清
    陈江汉
    ChineseMedicalJournal, 1998, (04)
  • [5] Identification of clinical and environmental isolates of Cryptococcus neoformans by AP-PCR fingerprinting
    Wen, H
    Wu, JH
    Liao, WQ
    Chen, JH
    Viviani, MA
    CHINESE MEDICAL JOURNAL, 1998, 111 (04) : 329 - 329
  • [6] Genotyping of Mexican Cryptococcus neoformans and C. gattii isolates by PCR-fingerprinting
    Castanon Olivares, L. R.
    Martinez Martinez, K.
    Bermudez Cruz, R. M.
    Martinez Rivera, M. A.
    Meyer, W.
    Arreguin Espinosa, R. A.
    Lopez Martinez, R.
    Ruiz Palacios Y Santos, G. M.
    MEDICAL MYCOLOGY, 2009, 47 (07) : 713 - 721
  • [7] Recovery of environmental Cryptococcus neoformans and Cryptococcus gattii in Cucuta and association with clinical isolates
    Angarita-Sanchez, Asbleide
    Cardenas-Sierra, Denny
    Parra-Giraldo, Claudia
    Diaz-Carvajal, Claudia
    Escandon-Hernandez, Patricia
    REVISTA MVZ CORDOBA, 2019, 24 (01) : 7137 - 7144
  • [9] Enzymatic characterisation of clinical isolates of Cryptococcus neoformans, Cryptococcus gattii and other environmental Cryptococcus spp.
    Chan, M. Y.
    Tay, S. T.
    MYCOSES, 2010, 53 (01) : 26 - 31
  • [10] Pathogenesis of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in human brain microvascular endothelial cells: A comparative analysis
    Mukhopadhyay, S. Lahiri
    Banerjee, A.
    Bhutda, S.
    Chandrashekar, N.
    Bahubali, V. H.
    MEDICAL MYCOLOGY, 2018, 56 : S28 - S28